Neurocrine Biosciences, Inc. (NBIX)
NASDAQ·Healthcare·Biotechnology
$159.23
+1.80%
Mkt Cap $15.73B
Analyst Ratings
Buy
26
Hold
3
Sell
0
Price Target (64 analysts)
$173.67
Range $140.00 – $220.00
Implied Upside
+9.1%
Consensus $173.67 vs current $159.23